The value of F-18-fluorodeoxyglucose positron emission tomography/computed tomography in carcinoma of an unknown primary: diagnosis and follow-up

Yapar, Zeynep; Kibar, MUSTAFA; Yapar, A.; Paydaş, SEMRA; Reyhan, Mehmet; Kara, Oguz; Buyukdereli, GÜLGÜN; Aydin, Mehmet; Kelle, Aygul; Ünal, İLKER; Disel, Umut; Yavuz, Sinan; Sahin, BERKSOY; Erkisi, Melek

doi:10.1097/mnm.0b013e328332b340

The value of F-18-fluorodeoxyglucose positron emission tomography/computed tomography in carcinoma of an unknown primary: diagnosis and follow-up

Atıf İçin Kopyala

Yapar Z., Kibar M., Yapar A. F., Paydaş S., Reyhan M., Kara O., ...Daha Fazla

NUCLEAR MEDICINE COMMUNICATIONS, cilt.31, ss.59-66, 2010 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 31
Basım Tarihi: 2010
Doi Numarası: 10.1097/mnm.0b013e328332b340
Dergi Adı: NUCLEAR MEDICINE COMMUNICATIONS
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.59-66
Çukurova Üniversitesi Adresli: Evet

Özet

Background The management of the patients with carcinoma of an unknown primary represents a difficult challenge in oncology. F-18-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) has provided new insights in the diagnosis, staging, and follow-up of oncological patients.